beta

ANIX

ITUS CORP

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

09-07-2018 03-09-2018
Actual EPS -0.3 -0.11
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Market Cap:

Primary Exchange:

Website: /stocks/anix

Shares Outstanding:

Float:

Dividend: (%)

Beta:

Sector:

Industry:

Short Interest ():

Ethical Flags

Longest drawdown: 125 trading days

From: 2018-10-17 To: 2019-04-18

Lowest Point:

Anixa Bio nabs a patent for CAR-T technology in U.S.

via: SeekingAlpha at 2019-04-17 05:15:51:000

The USPTO has issued Anixa Biosciences (NASDAQ: ANIX ) Patent No. 10,259,855, covering Company's CAR-T cancer treatment technology. More news on: Anixa Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Anixa Bio nabs a patent for CAR-T technology in U.S.

via: SeekingAlpha at 2019-04-17 05:15:51:000

The USPTO has issued Anixa Biosciences (NASDAQ: ANIX ) Patent No. 10,259,855, covering Company's CAR-T cancer treatment technology. More news on: Anixa Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Anixa Bio nabs a patent for CAR-T technology in U.S.

via: SeekingAlpha at 2019-04-17 05:15:51:000

The USPTO has issued Anixa Biosciences (NASDAQ: ANIX ) Patent No. 10,259,855, covering Company's CAR-T cancer treatment technology. More news on: Anixa Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

US Patent & Trademark Office Issues Patent on Anixa Biosciences CAR-T Cancer Treatment Technology

via: PR Newswire at 2019-04-17 03:00:00:000

SAN JOSE, Calif. , April 17, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that the United States Patent and Trademark Office ("USPTO") has issued US Patent No. 10,259,85… read more...

US Patent & Trademark Office Issues Patent on Anixa Biosciences CAR-T Cancer Treatment Technology

via: PR Newswire at 2019-04-17 03:00:00:000

SAN JOSE, Calif. , April 17, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that the United States Patent and Trademark Office ("USPTO") has issued US Patent No. 10,259,85… read more...

US Patent & Trademark Office Issues Patent on Anixa Biosciences CAR-T Cancer Treatment Technology

via: PR Newswire at 2019-04-17 03:00:00:000

SAN JOSE, Calif. , April 17, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that the United States Patent and Trademark Office ("USPTO") has issued US Patent No. 10,259,85… read more...

Anixa Biosciences Extends and Expands its Collaboration with New Jersey Urology

via: PR Newswire at 2019-04-11 03:00:00:000

SAN JOSE, Calif. , April 11, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it has extended and expanded its collaboration with New Jersey Urology, LLC ("NJU"). &#xA0… read more...

Anixa Biosciences Extends and Expands its Collaboration with New Jersey Urology

via: PR Newswire at 2019-04-11 03:00:00:000

SAN JOSE, Calif. , April 11, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it has extended and expanded its collaboration with New Jersey Urology, LLC ("NJU"). &#xA0… read more...

Anixa Biosciences Extends and Expands its Collaboration with New Jersey Urology

via: PR Newswire at 2019-04-11 03:00:00:000

SAN JOSE, Calif. , April 11, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it has extended and expanded its collaboration with New Jersey Urology, LLC ("NJU"). &#xA0… read more...

Anixa Biosciences Presents Cchek(TM) Prostate Cancer Detection Data at AACR Annual Meeting

via: PR Newswire at 2019-04-03 10:00:00:000

SAN JOSE, Calif. , April 3, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, presented the latest data from its ongoing study on prostate cancer detection, utilizing Cchek, its artificia… read more...

Anixa Biosciences Presents Cchek(TM) Prostate Cancer Detection Data at AACR Annual Meeting

via: PR Newswire at 2019-04-03 10:00:00:000

SAN JOSE, Calif. , April 3, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, presented the latest data from its ongoing study on prostate cancer detection, utilizing Cchek, its artificia… read more...

Anixa Biosciences Presents Cchek(TM) Prostate Cancer Detection Data at AACR Annual Meeting

via: PR Newswire at 2019-04-03 10:00:00:000

SAN JOSE, Calif. , April 3, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, presented the latest data from its ongoing study on prostate cancer detection, utilizing Cchek, its artificia… read more...

Anixa Biosciences CEO to Present at the New York Academy of Sciences Symposium on Cancer Immunotherapy

via: PR Newswire at 2019-03-27 03:00:00:000

SAN JOSE, Calif. , March 27, 2019 /PRNewswire/ -- Dr. Amit Kumar , CEO of Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, will participate in a panel presentation discussing the latest science in immunotherapy at … read more...

Anixa Biosciences CEO to Present at the New York Academy of Sciences Symposium on Cancer Immunotherapy

via: PR Newswire at 2019-03-27 03:00:00:000

SAN JOSE, Calif. , March 27, 2019 /PRNewswire/ -- Dr. Amit Kumar , CEO of Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, will participate in a panel presentation discussing the latest science in immunotherapy at … read more...

Anixa Biosciences CEO to Present at the New York Academy of Sciences Symposium on Cancer Immunotherapy

via: PR Newswire at 2019-03-27 03:00:00:000

SAN JOSE, Calif. , March 27, 2019 /PRNewswire/ -- Dr. Amit Kumar , CEO of Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, will participate in a panel presentation discussing the latest science in immunotherapy at … read more...

U.S. Department of Veterans Affairs and McGuire Research Institute Join Anixa Biosciences Cchek(TM) Prostate Cancer Study

via: PR Newswire at 2019-03-25 03:00:00:000

SAN JOSE, Calif. , March 25, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that the Hunter Holmes McGuire VA Medical Center (VAMC) located in Richmond, VA has joined it… read more...

U.S. Department of Veterans Affairs and McGuire Research Institute Join Anixa Biosciences Cchek(TM) Prostate Cancer Study

via: PR Newswire at 2019-03-25 03:00:00:000

SAN JOSE, Calif. , March 25, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that the Hunter Holmes McGuire VA Medical Center (VAMC) located in Richmond, VA has joined it… read more...

Anixa Biosciences Announces Notice of Allowance for Additional Cancer Detection Technology Patent

via: PR Newswire at 2019-03-14 03:00:00:000

SAN JOSE, Calif. , March 14, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that the United States Patent and Trademark Office ("USPTO") has issued a Notice of Allowance f… read more...

Anixa Biosciences Announces Notice of Allowance for Additional Cancer Detection Technology Patent

via: PR Newswire at 2019-03-14 03:00:00:000

SAN JOSE, Calif. , March 14, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that the United States Patent and Trademark Office ("USPTO") has issued a Notice of Allowance f… read more...

Anixa Biosciences Announces Notice of Allowance for Additional Cancer Detection Technology Patent

via: PR Newswire at 2019-03-14 03:00:00:000

SAN JOSE, Calif. , March 14, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that the United States Patent and Trademark Office ("USPTO") has issued a Notice of Allowance f… read more...

Anixa Biosciences to Present Cchek(TM) Technology and Data at the Molecular Medicine Tri-Conference

via: PR Newswire at 2019-03-04 02:00:00:000

SAN JOSE, Calif. , March 4, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present its Cchek artificial intelligence (AI) based liquid biopsy for the early… read more...

Anixa Biosciences to Present Cchek(TM) Technology and Data at the Molecular Medicine Tri-Conference

via: PR Newswire at 2019-03-04 02:00:00:000

SAN JOSE, Calif. , March 4, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present its Cchek artificial intelligence (AI) based liquid biopsy for the early… read more...

Anixa Biosciences to Present Cchek(TM) Technology and Data at the Molecular Medicine Tri-Conference

via: PR Newswire at 2019-03-04 02:00:00:000

SAN JOSE, Calif. , March 4, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present its Cchek artificial intelligence (AI) based liquid biopsy for the early… read more...

Anixa Biosciences to Present Latest Prostate Cancer Data at the 2019 American Association for Cancer Research (AACR) Annual Meeting

via: PR Newswire at 2019-02-28 07:00:00:000

SAN JOSE, Calif. , Feb. 28, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present data in an oral minisymposium presentation from its study utilizing Anixa's arti… read more...

Anixa Biosciences to Present Latest Prostate Cancer Data at the 2019 American Association for Cancer Research (AACR) Annual Meeting

via: PR Newswire at 2019-02-28 02:00:00:000

SAN JOSE, Calif. , Feb. 28, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present data in an oral minisymposium presentation from its study utilizing Anixa's arti… read more...

Anixa Biosciences to Present Latest Prostate Cancer Data at the 2019 American Association for Cancer Research (AACR) Annual Meeting

via: PR Newswire at 2019-02-28 02:00:00:000

SAN JOSE, Calif. , Feb. 28, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present data in an oral minisymposium presentation from its study utilizing Anixa's arti… read more...

Anixa Biosciences partners with ResearchDX for launch of Cchek PCC test

via: SeekingAlpha at 2019-02-25 08:55:18:000

Anixa Biosciences (NASDAQ: ANIX ) has entered into a strategic alliance with ResearchDx to launch its Cchek Prostate Cancer Confirmation (Cchek PCC) test as a Laboratory Developed Test. More news on: Anixa Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Anixa Biosciences partners with ResearchDX for launch of Cchek PCC test

via: SeekingAlpha at 2019-02-25 08:55:18:000

Anixa Biosciences (NASDAQ: ANIX ) has entered into a strategic alliance with ResearchDx to launch its Cchek Prostate Cancer Confirmation (Cchek PCC) test as a Laboratory Developed Test. More news on: Anixa Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Anixa Biosciences partners with ResearchDX for launch of Cchek PCC test

via: SeekingAlpha at 2019-02-25 08:55:18:000

Anixa Biosciences (NASDAQ: ANIX ) has entered into a strategic alliance with ResearchDx to launch its Cchek Prostate Cancer Confirmation (Cchek PCC) test as a Laboratory Developed Test. More news on: Anixa Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Anixa Biosciences Announces Partnership with ResearchDx for Launch of Cchek(TM) Prostate Cancer Confirmation Test

via: PR Newswire at 2019-02-25 07:00:00:000

SAN JOSE, Calif. , Feb. 25, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it has entered into a strategic alliance with ResearchDx to launch its Cchek Prosta… read more...

Anixa Biosciences Announces Partnership with ResearchDx for Launch of Cchek(TM) Prostate Cancer Confirmation Test

via: PR Newswire at 2019-02-25 07:00:00:000

SAN JOSE, Calif. , Feb. 25, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it has entered into a strategic alliance with ResearchDx to launch its Cchek Prosta… read more...

Anixa Biosciences Announces Partnership with ResearchDx for Launch of Cchek(TM) Prostate Cancer Confirmation Test

via: PR Newswire at 2019-02-25 07:00:00:000

SAN JOSE, Calif. , Feb. 25, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it has entered into a strategic alliance with ResearchDx to launch its Cchek Prosta… read more...

Anixa Biosciences Extends Collaborative Research Agreement with The Wistar Institute and Leading Myeloid-derived Suppressor Cell Researcher Dmitry I. Gabrilovich, M.D., Ph.D.

via: PR Newswire at 2019-02-21 07:00:00:000

SAN JOSE, Calif. , and PHILADELPHIA , Feb. 21, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced it has extended its collaboration with The Wistar Institute and Dmitry I…. read more...

Anixa Biosciences Extends Collaborative Research Agreement with The Wistar Institute and Leading Myeloid-derived Suppressor Cell Researcher Dmitry I. Gabrilovich, M.D., Ph.D.

via: PR Newswire at 2019-02-21 07:00:00:000

SAN JOSE, Calif. , and PHILADELPHIA , Feb. 21, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced it has extended its collaboration with The Wistar Institute and Dmitry I…. read more...

Anixa Biosciences Extends Collaborative Research Agreement with The Wistar Institute and Leading Myeloid-derived Suppressor Cell Researcher Dmitry I. Gabrilovich, M.D., Ph.D.

via: PR Newswire at 2019-02-21 07:00:00:000

SAN JOSE, Calif. , and PHILADELPHIA , Feb. 21, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced it has extended its collaboration with The Wistar Institute and Dmitry I…. read more...

Anixa Biosciences to Present at Moffitt Cancer Center's Business of Biotech Conference

via: PR Newswire at 2019-02-13 07:00:00:000

SAN JOSE, Calif. , Feb. 13, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that Dr. Amit Kumar , its President and CEO, will be presenting on a panel discussion at Moffitt Can… read more...

Anixa Biosciences to Present at Moffitt Cancer Center's Business of Biotech Conference

via: PR Newswire at 2019-02-13 07:00:00:000

SAN JOSE, Calif. , Feb. 13, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that Dr. Amit Kumar , its President and CEO, will be presenting on a panel discussion at Moffitt Can… read more...

Anixa Biosciences to Present at Moffitt Cancer Center's Business of Biotech Conference

via: PR Newswire at 2019-02-13 07:00:00:000

SAN JOSE, Calif. , Feb. 13, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that Dr. Amit Kumar , its President and CEO, will be presenting on a panel discussion at Moffitt Can… read more...

The Shutdown: View From The C-Suite

via: SeekingAlpha at 2019-01-25 12:13:22:000

Shutdown: View From The C Suite We're all here for investment research and analysis, and most of us would probably prefer to keep politics separate. But the government shutdown is dominating headlines on Bloomberg, The Wall Street Journal, and even the Financial Times across the pond, so we'… read more...

The Shutdown: View From The C-Suite

via: SeekingAlpha at 2019-01-25 12:13:22:000

Shutdown: View From The C Suite We're all here for investment research and analysis, and most of us would probably prefer to keep politics separate. But the government shutdown is dominating headlines on Bloomberg, The Wall Street Journal, and even the Financial Times across the pond, so we'… read more...

The Shutdown: View From The C-Suite

via: SeekingAlpha at 2019-01-25 12:13:22:000

Shutdown: View From The C Suite We're all here for investment research and analysis, and most of us would probably prefer to keep politics separate. But the government shutdown is dominating headlines on Bloomberg, The Wall Street Journal, and even the Financial Times across the pond, so we'… read more...

The Shutdown: View From The C-Suite

via: SeekingAlpha at 2019-01-25 12:13:22:000

Shutdown: View From The C Suite We're all here for investment research and analysis, and most of us would probably prefer to keep politics separate. But the government shutdown is dominating headlines on Bloomberg, The Wall Street Journal, and even the Financial Times across the pond, so we'… read more...

The Shutdown: View From The C-Suite

via: SeekingAlpha at 2019-01-25 12:13:22:000

Shutdown: View From The C Suite We're all here for investment research and analysis, and most of us would probably prefer to keep politics separate. But the government shutdown is dominating headlines on Bloomberg, The Wall Street Journal, and even the Financial Times across the pond, so we'… read more...

Anixa Biosciences Conference Call Recording Available on Company Website

via: PR Newswire at 2019-01-25 07:00:00:000

SAN JOSE, Calif. , Jan. 25, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it has made a recording of its January 24, 2019 conference call available on its website. &#xA… read more...

Anixa Biosciences Conference Call Recording Available on Company Website

via: PR Newswire at 2019-01-25 07:00:00:000

SAN JOSE, Calif. , Jan. 25, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it has made a recording of its January 24, 2019 conference call available on its website. &#xA… read more...

Anixa Biosciences Conference Call Recording Available on Company Website

via: PR Newswire at 2019-01-25 07:00:00:000

SAN JOSE, Calif. , Jan. 25, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it has made a recording of its January 24, 2019 conference call available on its website. &#xA… read more...

Anixa Biosciences Conference Call Recording Available on Company Website

via: PR Newswire at 2019-01-25 07:00:00:000

SAN JOSE, Calif. , Jan. 25, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it has made a recording of its January 24, 2019 conference call available on its website. &#xA… read more...

Anixa Biosciences Conference Call Recording Available on Company Website

via: PR Newswire at 2019-01-25 07:00:00:000

SAN JOSE, Calif. , Jan. 25, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it has made a recording of its January 24, 2019 conference call available on its website. &#xA… read more...

Anixa Biosciences, Inc. (ANIX) CEO Amit Kumar on Outlook for 2019 Transcript

via: SeekingAlpha at 2019-01-24 22:11:17:000

Anixa Biosciences, Inc. (ANIX) Outlook for 2019 January 24, 2019, 04:30 PM ET Company Participants Amit Kumar - Chairman, President and CEO Mike Catelani - COO and CFO Lewis Titterton - Lead Independent Director Conference Call Participants Jason Kolbert - Dawson James An… read more...

Anixa Biosciences, Inc. (ANIX) CEO Amit Kumar on Outlook for 2019 Transcript

via: SeekingAlpha at 2019-01-24 22:11:17:000

Anixa Biosciences, Inc. (ANIX) Outlook for 2019 January 24, 2019, 04:30 PM ET Company Participants Amit Kumar - Chairman, President and CEO Mike Catelani - COO and CFO Lewis Titterton - Lead Independent Director Conference Call Participants Jason Kolbert - Dawson James An… read more...

Anixa Biosciences, Inc. (ANIX) CEO Amit Kumar on Outlook for 2019 Transcript

via: SeekingAlpha at 2019-01-24 22:11:17:000

Anixa Biosciences, Inc. (ANIX) Outlook for 2019 January 24, 2019, 04:30 PM ET Company Participants Amit Kumar - Chairman, President and CEO Mike Catelani - COO and CFO Lewis Titterton - Lead Independent Director Conference Call Participants Jason Kolbert - Dawson James An… read more...

Anixa Biosciences, Inc. (ANIX) CEO Amit Kumar on Outlook for 2019 Transcript

via: SeekingAlpha at 2019-01-24 22:11:17:000

Anixa Biosciences, Inc. (ANIX) Outlook for 2019 January 24, 2019, 04:30 PM ET Company Participants Amit Kumar - Chairman, President and CEO Mike Catelani - COO and CFO Lewis Titterton - Lead Independent Director Conference Call Participants Jason Kolbert - Dawson James An… read more...

Anixa Biosciences, Inc. (ANIX) CEO Amit Kumar on Outlook for 2019 Transcript

via: SeekingAlpha at 2019-01-24 22:11:17:000

Anixa Biosciences, Inc. (ANIX) Outlook for 2019 January 24, 2019, 04:30 PM ET Company Participants Amit Kumar - Chairman, President and CEO Mike Catelani - COO and CFO Lewis Titterton - Lead Independent Director Conference Call Participants Jason Kolbert - Dawson James An… read more...

Anixa Biosciences CAR-T Cancer Therapy Patent Receives Notice of Allowance

via: PR Newswire at 2019-01-24 07:00:00:000

SAN JOSE, Calif. , Jan. 24, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for the first patent … read more...

Key events next week - healthcare

via: SeekingAlpha at 2019-01-18 07:08:29:000

Noteworthy events during the week of January 20 - 26 for healthcare investors. More news on: Lipocine Inc., Cue Biopharma, Johnson & Johnson, Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2019-01-18 07:08:29:000

Noteworthy events during the week of January 20 - 26 for healthcare investors. More news on: Lipocine Inc., Cue Biopharma, Johnson & Johnson, Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2019-01-18 07:08:29:000

Noteworthy events during the week of January 20 - 26 for healthcare investors. More news on: Lipocine Inc., Cue Biopharma, Johnson & Johnson, Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2019-01-18 07:08:29:000

Noteworthy events during the week of January 20 - 26 for healthcare investors. More news on: Lipocine Inc., Cue Biopharma, Johnson & Johnson, Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2019-01-18 07:08:29:000

Noteworthy events during the week of January 20 - 26 for healthcare investors. More news on: Lipocine Inc., Cue Biopharma, Johnson & Johnson, Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2019-01-18 07:08:29:000

Noteworthy events during the week of January 20 - 26 for healthcare investors. More news on: Lipocine Inc., Cue Biopharma, Johnson & Johnson, Healthcare stocks news, , Read more … read more...

Anixa Biosciences to Hold Conference Call to Discuss Outlook for 2019

via: PR Newswire at 2019-01-16 07:30:00:000

SAN JOSE, Calif. , Jan. 16, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will hold a conference call on January 24, 2019 at 1:30 p.m. Pacific / 4:30 p.m. E… read more...

Anixa Biosciences to Hold Conference Call to Discuss Outlook for 2019

via: PR Newswire at 2019-01-16 07:30:00:000

SAN JOSE, Calif. , Jan. 16, 2019 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will hold a conference call on January 24, 2019 at 1:30 p.m. Pacific / 4:30 p.m. E… read more...

Anixa Biosciences completes Pre-Sub meeting with FDA for Cchek cancer diagnostic test

via: SeekingAlpha at 2018-12-19 08:43:09:000

Anixa Biosciences (NASDAQ: ANIX ) has completed a Pre-Submission (Pre-Sub) meeting with the FDA on December 17. More news on: Anixa Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Anixa Biosciences completes Pre-Sub meeting with FDA for Cchek cancer diagnostic test

via: SeekingAlpha at 2018-12-19 08:43:09:000

Anixa Biosciences (NASDAQ: ANIX ) has completed a Pre-Submission (Pre-Sub) meeting with the FDA on December 17. More news on: Anixa Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Anixa Biosciences completes Pre-Sub meeting with FDA for Cchek cancer diagnostic test

via: SeekingAlpha at 2018-12-19 08:43:09:000

Anixa Biosciences (NASDAQ: ANIX ) has completed a Pre-Submission (Pre-Sub) meeting with the FDA on December 17. More news on: Anixa Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Anixa Biosciences Announces Completion of Pre-Sub Meeting with FDA for its Cchek(TM) Cancer Diagnostic Test

via: PR Newswire at 2018-12-19 07:00:00:000

SAN JOSE, Calif. , Dec. 19, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it completed a Pre-Submission (Pre-Sub) meeting with the US FDA on December 17 , 2018.&#xA… read more...

Anixa Biosciences Announces Completion of Pre-Sub Meeting with FDA for its Cchek(TM) Cancer Diagnostic Test

via: PR Newswire at 2018-12-19 07:00:00:000

SAN JOSE, Calif. , Dec. 19, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it completed a Pre-Submission (Pre-Sub) meeting with the US FDA on December 17 , 2018.&#xA… read more...

Anixa Biosciences Announces Completion of Pre-Sub Meeting with FDA for its Cchek(TM) Cancer Diagnostic Test

via: PR Newswire at 2018-12-19 07:00:00:000

SAN JOSE, Calif. , Dec. 19, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it completed a Pre-Submission (Pre-Sub) meeting with the US FDA on December 17 , 2018.&#xA… read more...

Anixa Biosciences Presents Positive Data on its Liquid Biopsy for Early Detection of Breast Cancer at AACR Conference

via: PR Newswire at 2018-12-03 07:00:00:000

SAN JOSE, Calif. , Dec. 3, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, presented the latest data from its ongoing study focusing on early detection of breast cancer, utilizing Cchek&#x… read more...

Anixa Biosciences Presents Positive Data on its Liquid Biopsy for Early Detection of Breast Cancer at AACR Conference

via: PR Newswire at 2018-12-03 07:00:00:000

SAN JOSE, Calif. , Dec. 3, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, presented the latest data from its ongoing study focusing on early detection of breast cancer, utilizing Cchek&#x… read more...

Anixa Biosciences Presents Positive Data on its Liquid Biopsy for Early Detection of Breast Cancer at AACR Conference

via: PR Newswire at 2018-12-03 07:00:00:000

SAN JOSE, Calif. , Dec. 3, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, presented the latest data from its ongoing study focusing on early detection of breast cancer, utilizing Cchek&#x… read more...

Anixa Biosciences To Present Cchek(TM) Breast Cancer Data at AACR Special Conference on Tumor Immunology and Immunotherapy

via: PR Newswire at 2018-11-15 07:00:00:000

SAN JOSE, Calif. , Nov. 15, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present data from its ongoing studies in breast cancer utilizing Cchek, Ani… read more...

Anixa Biosciences To Present Cchek(TM) Breast Cancer Data at AACR Special Conference on Tumor Immunology and Immunotherapy

via: PR Newswire at 2018-11-15 07:00:00:000

SAN JOSE, Calif. , Nov. 15, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present data from its ongoing studies in breast cancer utilizing Cchek, Ani… read more...

Anixa Biosciences To Present Cchek(TM) Breast Cancer Data at AACR Special Conference on Tumor Immunology and Immunotherapy

via: PR Newswire at 2018-11-15 07:00:00:000

SAN JOSE, Calif. , Nov. 15, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present data from its ongoing studies in breast cancer utilizing Cchek, Ani… read more...

Anixa Biosciences Presents Positive Data from its Artificial Intelligence Powered Liquid Biopsy for Prostate Cancer at SITC Conference

via: PR Newswire at 2018-11-12 07:00:00:000

SAN JOSE, Calif. , Nov. 12, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that its two presentations at the 33 rd Annual Meeting of The Society for Immunotherapy of… read more...

Anixa Biosciences Presents Positive Data from its Artificial Intelligence Powered Liquid Biopsy for Prostate Cancer at SITC Conference

via: PR Newswire at 2018-11-12 07:00:00:000

SAN JOSE, Calif. , Nov. 12, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that its two presentations at the 33 rd Annual Meeting of The Society for Immunotherapy of… read more...

Anixa Biosciences Presents Positive Data from its Artificial Intelligence Powered Liquid Biopsy for Prostate Cancer at SITC Conference

via: PR Newswire at 2018-11-12 07:00:00:000

SAN JOSE, Calif. , Nov. 12, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that its two presentations at the 33 rd Annual Meeting of The Society for Immunotherapy of… read more...

Anixa Biosciences to Present at SITC Annual Meeting

via: PR Newswire at 2018-10-29 07:00:00:000

SAN JOSE, Calif. , Oct. 29, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present data from its ongoing studies utilizing Cchek, Anixa's artificial i… read more...

Anixa Biosciences to Present at SITC Annual Meeting

via: PR Newswire at 2018-10-29 07:00:00:000

SAN JOSE, Calif. , Oct. 29, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present data from its ongoing studies utilizing Cchek, Anixa's artificial i… read more...

Anixa Biosciences to Present at SITC Annual Meeting

via: PR Newswire at 2018-10-29 07:00:00:000

SAN JOSE, Calif. , Oct. 29, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present data from its ongoing studies utilizing Cchek, Anixa's artificial i… read more...

Anixa Biosciences Announces Scheduling of Pre-Sub Meeting with FDA for its Cchek(TM) Cancer Diagnostic Test

via: PR Newswire at 2018-10-24 07:00:00:000

SAN JOSE, Calif. , Oct. 24, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that a Pre-Submission (Pre-Sub) meeting with the US FDA has been scheduled on Monday, December … read more...

Anixa Biosciences Announces Scheduling of Pre-Sub Meeting with FDA for its Cchek(TM) Cancer Diagnostic Test

via: PR Newswire at 2018-10-24 07:00:00:000

SAN JOSE, Calif. , Oct. 24, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that a Pre-Submission (Pre-Sub) meeting with the US FDA has been scheduled on Monday, December … read more...

Anixa Biosciences Announces Scheduling of Pre-Sub Meeting with FDA for its Cchek(TM) Cancer Diagnostic Test

via: PR Newswire at 2018-10-24 07:00:00:000

SAN JOSE, Calif. , Oct. 24, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that a Pre-Submission (Pre-Sub) meeting with the US FDA has been scheduled on Monday, December … read more...

Moffitt Cancer Center and Anixa Biosciences Announce Completion of Pre-IND Meeting with FDA for CAR-T Therapy

via: PR Newswire at 2018-10-22 07:00:00:000

SAN JOSE, Calif. , Oct. 22, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it, along with its partner Moffitt Cancer Center (MCC), completed a pre-IND (Investigationa… read more...

Moffitt Cancer Center and Anixa Biosciences Announce Completion of Pre-IND Meeting with FDA for CAR-T Therapy

via: PR Newswire at 2018-10-22 07:00:00:000

SAN JOSE, Calif. , Oct. 22, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it, along with its partner Moffitt Cancer Center (MCC), completed a pre-IND (Investigationa… read more...

Anixa Biosciences Releases Data Presented at AACR Artificial Intelligence Conference

via: PR Newswire at 2018-10-17 07:00:00:000

SAN JOSE, Calif. , Oct. 17, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, presented the results from its ongoing study utilizing Cchek, its artificial intelligence (AI) driven ea… read more...

Anixa Biosciences Releases Data Presented at AACR Artificial Intelligence Conference

via: PR Newswire at 2018-10-17 07:00:00:000

SAN JOSE, Calif. , Oct. 17, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, presented the results from its ongoing study utilizing Cchek, its artificial intelligence (AI) driven ea… read more...

Anixa Biosciences Releases Data Presented at AACR Artificial Intelligence Conference

via: PR Newswire at 2018-10-17 07:00:00:000

SAN JOSE, Calif. , Oct. 17, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, presented the results from its ongoing study utilizing Cchek, its artificial intelligence (AI) driven ea… read more...

Midday Gainers / Losers (10/15/2018)

via: SeekingAlpha at 2018-10-15 12:38:14:000

Gainers: KRYS +29% . ABCD +20% . SLS +19% . YGYI +18% . NBEV +15% . XTLB +15% . ANIX +13% . SCWX +12% . LLL +11% . CGC +11% . More news on: Krystal Biotech, Cambium Learning Group, Inc., SELLAS Life Sciences Group, Inc., Stocks on the move, , Top stock… read more...

Midday Gainers / Losers (10/15/2018)

via: SeekingAlpha at 2018-10-15 12:38:14:000

Gainers: KRYS +29% . ABCD +20% . SLS +19% . YGYI +18% . NBEV +15% . XTLB +15% . ANIX +13% . SCWX +12% . LLL +11% . CGC +11% . More news on: Krystal Biotech, Cambium Learning Group, Inc., SELLAS Life Sciences Group, Inc., Stocks on the move, , Top stock… read more...

Anixa Biosciences Files Pre-Submission and Requests Meeting with FDA Regarding Cchek(TM) Artificial Intelligence based Cancer Detection Technology

via: PR Newswire at 2018-10-15 07:00:00:000

SAN JOSE, Calif. , Oct. 15, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced it has filed an IVD pre-submission with the US Food and Drug Administration (FDA) for use of its… read more...

Anixa Biosciences Files Pre-Submission and Requests Meeting with FDA Regarding Cchek(TM) Artificial Intelligence based Cancer Detection Technology

via: PR Newswire at 2018-10-15 07:00:00:000

SAN JOSE, Calif. , Oct. 15, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced it has filed an IVD pre-submission with the US Food and Drug Administration (FDA) for use of its… read more...

Anixa Biosciences Appoints Leading Researchers in Immuno-Oncology to its Scientific Advisory Board

via: PR Newswire at 2018-10-11 07:00:00:000

SAN JOSE, Calif. , Oct. 11, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it has added to its Scientific Advisory Board, Jose Conejo-Garcia , MD PhD; Marco Davila … read more...

Anixa Biosciences Appoints Leading Researchers in Immuno-Oncology to its Scientific Advisory Board

via: PR Newswire at 2018-10-11 07:00:00:000

SAN JOSE, Calif. , Oct. 11, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it has added to its Scientific Advisory Board, Jose Conejo-Garcia , MD PhD; Marco Davila … read more...

Anixa Biosciences Appoints Leading Researchers in Immuno-Oncology to its Scientific Advisory Board

via: PR Newswire at 2018-10-11 07:00:00:000

SAN JOSE, Calif. , Oct. 11, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it has added to its Scientific Advisory Board, Jose Conejo-Garcia , MD PhD; Marco Davila … read more...

Anixa Biosciences Could Rock The Foundation Of The Cancer Diagnostics Industry

via: SeekingAlpha at 2018-10-05 14:30:11:000

Introduction In this article, I will explain how Anixa Biosciences ( ANIX ), formerly ITUS Corporation (ITUS), a biotechnology company focusing on cancer diagnostics for all cancers and CAR-T cell immunotherapy for ovarian cancer, could have a profound impact on the cancer diagnostics in… read more...

Anixa Biosciences Could Rock The Foundation Of The Cancer Diagnostics Industry

via: SeekingAlpha at 2018-10-05 14:30:11:000

Introduction In this article, I will explain how Anixa Biosciences ( ANIX ), formerly ITUS Corporation (ITUS), a biotechnology company focusing on cancer diagnostics for all cancers and CAR-T cell immunotherapy for ovarian cancer, could have a profound impact on the cancer diagnostics in… read more...

Anixa Biosciences Could Rock The Foundation Of The Cancer Diagnostics Industry

via: SeekingAlpha at 2018-10-05 14:30:11:000

Introduction In this article, I will explain how Anixa Biosciences ( ANIX ), formerly ITUS Corporation (ITUS), a biotechnology company focusing on cancer diagnostics for all cancers and CAR-T cell immunotherapy for ovarian cancer, could have a profound impact on the cancer diagnostics in… read more...

Anixa Biosciences Could Rock The Foundation Of The Cancer Diagnostics Industry

via: SeekingAlpha at 2018-10-05 14:30:11:000

Introduction In this article, I will explain how Anixa Biosciences ( ANIX ), formerly ITUS Corporation (ITUS), a biotechnology company focusing on cancer diagnostics for all cancers and CAR-T cell immunotherapy for ovarian cancer, could have a profound impact on the cancer diagnostics in… read more...

Anixa Biosciences Could Rock The Foundation Of The Cancer Diagnostics Industry

via: SeekingAlpha at 2018-10-05 14:30:11:000

Introduction In this article, I will explain how Anixa Biosciences ( ANIX ), formerly ITUS Corporation (ITUS), a biotechnology company focusing on cancer diagnostics for all cancers and CAR-T cell immunotherapy for ovarian cancer, could have a profound impact on the cancer diagnostics in… read more...

Anixa Biosciences to Present at Artificial Intelligence Conference

via: PR Newswire at 2018-10-05 07:00:00:000

SAN JOSE, Calif. , Oct. 5, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present data from its ongoing studies utilizing Cchek, Anixa's artificial in… read more...

Anixa Biosciences to Present at Artificial Intelligence Conference

via: PR Newswire at 2018-10-05 07:00:00:000

SAN JOSE, Calif. , Oct. 5, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present data from its ongoing studies utilizing Cchek, Anixa's artificial in… read more...

Anixa Biosciences to Present at Artificial Intelligence Conference

via: PR Newswire at 2018-10-05 07:00:00:000

SAN JOSE, Calif. , Oct. 5, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present data from its ongoing studies utilizing Cchek, Anixa's artificial in… read more...

Anixa Biosciences to Present at Artificial Intelligence Conference

via: PR Newswire at 2018-10-05 07:00:00:000

SAN JOSE, Calif. , Oct. 5, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present data from its ongoing studies utilizing Cchek, Anixa's artificial in… read more...

Anixa Biosciences to Present at Artificial Intelligence Conference

via: PR Newswire at 2018-10-05 07:00:00:000

SAN JOSE, Calif. , Oct. 5, 2018 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present data from its ongoing studies utilizing Cchek, Anixa's artificial in… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX